QA: Aerovate Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001798749_2023_Aerovate_Therapeutics_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001798749, Aerovate Therapeutics Inc.

  xvar xval
0 AssetsCurrent 131,496,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 242,000
3 remainder_Assets 3,563,000
4 LiabilitiesCurrent 7,782,000
5 LiabilitiesNoncurrent 705,000
6 remainder_Liabilities 71,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,615,000
9 ResearchAndDevelopmentExpense 38,622,000
10 remainder_Expenses 25,000
11 remainder_Revenues 0
12 remainder_NetIncome 1,751,000
13 remainder_ComprehensiveNetIncome -407,000
  yvar yval
0 Assets 135,301,000
1 Liabilities 8,558,000
2 Expenses 53,262,000
3 Revenues 0
4 StockholdersEquity 126,743,000
5 NetIncome -51,511,000
6 ComprehensiveNetIncome -51,714,500
7 BaseVar 99,639,500
8 EconomicCapitalRatio 2.31

Edgar->Model Mapping

Feature Distribution

Change over Time